|
organizations, pharmaceutical manufacturers,
pharmacists,
|
dispensing pharmacies, physicians, and providers of services |
to senior
citizens.
No single organization may have more than |
one representative appointed as a
member from the general |
public.
|
(c) The President of the Senate and Speaker of the House of
|
Representatives shall each designate one member of the |
Committee to serve as
co-chairs.
|
(d) Committee members shall serve without compensation or
|
reimbursement for expenses.
|
(e) The Committee shall meet at the call of the co-chairs, |
but at
least quarterly.
|
(f) The Committee may conduct public hearings to gather |
testimony
from interested parties regarding pharmaceutical |
assistance for Illinois
seniors, including changes to existing |
and proposed programs.
|
(g) The Committee may advise appropriate State agencies |
regarding
the establishment of proposed programs or changes to |
existing programs. The
State agencies shall take into |
consideration any recommendations made by the
Committee.
|
(h) The Committee shall report to the General Assembly and |
the
Governor annually or as it deems necessary regarding |
proposed or recommended
changes to pharmaceutical assistance |
programs that benefit Illinois seniors and
any associated costs |
of those changes.
|
(i) In the event that a prescription drug benefit is added |
to the federal
Medicare
program, the Committee shall make |
recommendations for the realignment of State-operated senior |
prescription drug programs so
that Illinois residents qualify |
for at least substantially the same level of benefits
available |
to them prior
to implementation of the Medicare prescription |
drug benefit, provided that a resident remains eligible for |
such a State-operated program. The Committee shall report its |
recommendations to the General
Assembly and
the Governor by |
January 1, 2005.
|
(Source: P.A. 92-594, eff. 6-27-02.)
|